The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Chemopreventive strategies in hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is the third most common cause of death from cancer. The incidence and mortality of HCC are increasing in most Western countries as a result of an ageing cohort infected with chronic hepatitis C, and are expected to continue to rise as a consequence of the obesity epidemic. Chemopreventive strategies aimed at decreasing the risk or delaying the onset of HCC are needed. Universal immunization against HBV and antiviral therapy against HBV and HCV in patients with established disease has consistently been associated with reduced HCC risk, especially in patients who achieve sustained virologic response. However, the cost-effectiveness of antiviral therapy for primary HCC prevention is not known. Several commonly prescribed medications seem promising as chemopreventive agents against HCC, including statins, antidiabetic medications and aspirin. Dietary agents such as coffee, vitamin E and fish oil as well as phytochemicals might also be associated with reduced risk of HCC. Though randomized controlled trials are ideally needed to firmly establish efficacy, such chemoprevention trials are logistically and ethically challenging. Well-designed, prospective, population-based cohort studies might provide the best evidence for chemopreventive efficacy of these agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,289
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Fattovich, G., Bortolotti, F., & Donato, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.011 · Cited by 1,348
Hepatocellular carcinoma: a global view
Yang, J. D., & Roberts, L. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.100 · Cited by 1,286
Self-citationCurcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, Å., Beer, S., Mandl, S., Bachmann, M. H., Borowsky, A. D., Ruebner, B., Cardiff, R. D., et al. (2004) · Nature · doi:10.1038/nature03043 · Cited by 874
Thein, H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · Hepatology · doi:10.1002/hep.22375 · Cited by 829
Morgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Demierre, M.-F., Higgins, P. D. R., Gruber, S. B., Hawk, E., & Lippman, S. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1751 · Cited by 819
Wu, C.-Y., Chen, Y.-J., Ho, H. J., Hsu, Y.-C., Kuo, K. N., Wu, M.-S., & Lin, J.-T. (2012) · JAMA · doi:10.1001/2012.jama.11975 · Cited by 818
A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis
Li, S., Tang, T., Guo, P., Zou, Q., Ao, X., Hu, L., & Tan, L. (2019) · Medicine · doi:10.1097/md.0000000000014733 · Cited by 802
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Arzumanyan, A., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3449 · Cited by 800
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766
Hosaka, T., Suzuki, F., Kobayashi, M., Seko, Y., Kawamura, Y., Sezaki, H., Akuta, N., Suzuki, Y., Saitoh, S., Arase, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26180 · Cited by 710
Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L., Laczy, B., Cseh, J., Mikolás, E., Szijártó, I. A., Mérei, Á., Halmai, R., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511000316 · Cited by 678
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Chang, M.-H., You, S.-L., Chen, C.-J., Liu, C.-J., Lee, C.-M., Lin, S.-M., Chu, H.-C., Wu, T.-C., Yang, S.-S., Kuo, H.-S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp288 · Cited by 635
Molecular mechanisms of hepatocellular carcinoma
Aravalli, R. N., Steer, C. J., & Cressman, E. N. K. (2008) · Hepatology · doi:10.1002/hep.22580 · Cited by 625
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
IMS Institute for Healthcare Informatics
Evans, R. (2014) · Nursing Standard · doi:10.7748/ns2014.04.28.32.30.s36 · Cited by 594
Genomics and Signaling Pathways in Hepatocellular Carcinoma
Villanueva, A., Newell, P., Chiang, D., Friedman, S., & Llovet, J. (2007) · Seminars in Liver Disease · doi:10.1055/s-2006-960171 · Cited by 556
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00008 · Cited by 533
Metformin and the Risk of Cancer
Suissa, S., & Azoulay, L. (2012) · Diabetes Care · doi:10.2337/dc12-0788 · Cited by 531
The role of aspirin in cancer prevention
Thun, M. J., Jacobs, E. J., & Patrono, C. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.199 · Cited by 481
Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C†,‡,§,¶
Morgan, T. R., Ghany, M. G., Kim, H.-Y., Snow, K. K., Shiffman, M. L., De Santo, J. L., Lee, W. M., Di Bisceglie, A. M., Bonkovsky, H. L., Dienstag, J. L., et al. (2010) · Hepatology · doi:10.1002/hep.23744 · Cited by 479
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
White, B. D., Chien, A. J., & Dawson, D. W. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.001 · Cited by 469
Hamelin, B. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01147-4 · Cited by 468
Papatheodoridis, G. V., Lampertico, P., Manolakopoulos, S., & Lok, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.035 · Cited by 459
High-Dose Resveratrol Supplementation in Obese Men
Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stødkilde-Jørgensen, H., Møller, N., Jessen, N., Pedersen, S. B., & Jørgensen, J. O. L. (2013) · Diabetes · doi:10.2337/db12-0975 · Cited by 455
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.005 · Cited by 452
Self-citationChen, H.-P., Shieh, J.-J., Chang, C.-C., Chen, T.-T., Lin, J.-T., Wu, M.-S., Lin, J.-H., & Wu, C.-Y. (2013) · Gut · doi:10.1136/gutjnl-2011-301708 · Cited by 392
Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
SUNG, J. J. Y., TSOI, K. K. F., WONG, V. W. S., LI, K. C. T., & CHAN, H. L. Y. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03816.x · Cited by 370
Keap1–Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane
Kensler, T. W., Egner, P. A., Agyeman, A. S., Visvanathan, K., Groopman, J. D., Chen, J.-G., Chen, T.-Y., Fahey, J. W., & Talalay, P. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_339 · Cited by 361
Platelets mediate cytotoxic T lymphocyte–induced liver damage
Iannacone, M., Sitia, G., Isogawa, M., Marchese, P., Castro, M. G., Lowenstein, P. R., Chisari, F. V., Ruggeri, Z. M., & Guidotti, L. G. (2005) · Nature Medicine · doi:10.1038/nm1317 · Cited by 355
Cholesterol Treatment Trialists' (CTT) Collaboration (2012) · PLoS ONE · doi:10.1371/journal.pone.0029849 · Cited by 351
Rao, S., Porter, D. C., Chen, X., Herliczek, T., Lowe, M., & Keyomarsi, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7797 · Cited by 345
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.5 · Cited by 320
Self-citationSitia, G., Aiolfi, R., Di Lucia, P., Mainetti, M., Fiocchi, A., Mingozzi, F., Esposito, A., Ruggeri, Z. M., Chisari, F. V., Iannacone, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209182109 · Cited by 317
Kensler, T. W., Chen, J.-G., Egner, P. A., Fahey, J. W., Jacobson, L. P., Stephenson, K. K., Ye, L., Coady, J. L., Wang, J.-B., Wu, Y., et al. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0368 · Cited by 317
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
Hassan, M. M., Curley, S. A., Li, D., Kaseb, A., Davila, M., Abdalla, E. K., Javle, M., Moghazy, D. M., Lozano, R. D., Abbruzzese, J. L., et al. (2010) · Cancer · doi:10.1002/cncr.24982 · Cited by 309
Egner, P. A., Wang, J.-B., Zhu, Y.-R., Zhang, B.-C., Wu, Y., Zhang, Q.-N., Qian, G.-S., Kuang, S.-Y., Gange, S. J., Jacobson, L. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251536898 · Cited by 301
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Tsan, Y.-T., Lee, C.-H., Wang, J.-D., & Chen, P.-C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.0917 · Cited by 294
El–Serag, H. B., Johnson, M. L., Hachem, C., & Morgana, R. O. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.053 · Cited by 291
Hepatocellular Carcinoma: Molecular Pathways and New Therapeutic Targets
Roberts, L. R., & Gores, G. J. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871200 · Cited by 289
Self-citationCirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., Sanderson, S. O., Therneau, T. M., Kim, B., & Roberts, L. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.08.019 · Cited by 266
Self-citationMetformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
Blandino, G., Valerio, M., Cioce, M., Mori, F., Casadei, L., Pulito, C., Sacconi, A., Biagioni, F., Cortese, G., Galanti, S., et al. (2012) · Nature Communications · doi:10.1038/ncomms1859 · Cited by 242
El-Serag, H. B., Siegel, A. B., Davila, J. A., Shaib, Y. H., Cayton-Woody, M., McBride, R., & McGlynn, K. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.002 · Cited by 232
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives
Ruiter, R., Visser, L. E., van Herk-Sukel, M. P. P., Coebergh, J.-W. W., Haak, H. R., Geelhoed-Duijvestijn, P. H., Straus, S. M. J. M., Herings, R. M. C., & Stricker, B. H. C. (2012) · Diabetes Care · doi:10.2337/dc11-0857 · Cited by 232
Coffee drinking and hepatocellular carcinoma risk: A meta‐analysis†
Bravi, F., Bosetti, C., Tavani, A., Bagnardi, V., Gallus, S., Negri, E., Franceschi, S., & La Vecchia, C. (2007) · Hepatology · doi:10.1002/hep.21708 · Cited by 227
Wu, J., Wong, W. W.-L., Khosravi, F., Minden, M. D., & Penn, L. Z. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0866 · Cited by 225
Inoue, M., Yoshimi, I., Sobue, T., Tsugane, S., & For the JPHC Study Group (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji040 · Cited by 225
Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
Sahasrabuddhe, V. V., Gunja, M. Z., Graubard, B. I., Trabert, B., Schwartz, L. M., Park, Y., Hollenbeck, A. R., Freedman, N. D., & McGlynn, K. A. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs452 · Cited by 222
Loomba, R., Yang, H.-I., Su, J., Brenner, D., Barrett-Connor, E., Iloeje, U., & Chen, C.-J. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws252 · Cited by 221
Rein, D. B., Wittenborn, J. S., Weinbaum, C. M., Sabin, M., Smith, B. D., & Lesesne, S. B. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.05.006 · Cited by 211
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
Marcelli, M., Cunningham, G. R., Haidacher, S. J., Padayatty, S. J., Sturgis, L., Kagan, C., & Denner, L. A. (1998) · PubMed · Cited by 210
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Tsan, Y.-T., Lee, C.-H., Ho, W.-C., Lin, M.-H., Wang, J.-D., & Chen, P.-C. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.6831 · Cited by 210
Prevention of hepatitis B virus–related hepatocellular carcinoma with antiviral therapy
Lai, C.-L., & Yuen, M.-F. (2013) · Hepatology · doi:10.1002/hep.25937 · Cited by 208
Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma
Bishayee, A., Politis, T., & Darvesh, A. S. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.10.002 · Cited by 204
Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma
Sawada, N., Inoue, M., Iwasaki, M., Sasazuki, S., Shimazu, T., Yamaji, T., Takachi, R., Tanaka, Y., Mizokami, M., & Tsugane, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.018 · Cited by 196
Chang, C.-H., Lin, J.-W., Wu, L.-C., Lai, M.-S., Chuang, L.-M., & Chan, K. A. (2012) · Hepatology · doi:10.1002/hep.25509 · Cited by 193
The Increasing Incidence of Hepatocellular Carcinoma
Ince, N., & Wands, J. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401009 · Cited by 189
GELATTI, U., COVOLO, L., FRANCESCHINI, M., PIRALI, F., TAGGER, A., RIBERO, M., TREVISI, P., MARTELLI, C., NARDI, G., & DONATO, F. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.039 · Cited by 186
Singh, S., Singh, A. G., Singh, P. P., Murad, M. H., & Iyer, P. G. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.036 · Cited by 180
Self-citationMeta-analysis of Observational Studies
Greenwood, D. C. (2012) · Modern Methods for Epidemiology · doi:10.1007/978-94-007-3024-3_10 · Cited by 179
Cao, Z., Fan-Minogue, H., Bellovin, D. I., Yevtodiyenko, A., Arzeno, J., Yang, Q., Gambhir, S. S., & Felsher, D. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3367 · Cited by 178
Luo, Z., Li, L., & Ruan, B. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.10.009 · Cited by 176
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis
Nahon, P., & Zucman-Rossi, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.035 · Cited by 176
Ikeda, K., Saitoh, S., Suzuki, Y., Kobayashi, M., Tsubota, A., Fukuda, M., Koida, I., Arase, Y., Chayama, K., Murashima, N., et al. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980301)82:5<827::aid-cncr5>3.0.co;2-g · Cited by 175
Systematic Review and Meta‐Analysis
(2023) · Textbook of Epidemiology, Second Edition · doi:10.1002/9781394323104.ch11 · Cited by 168
Bishayee, A., & Dhir, N. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.11.015 · Cited by 167
Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells
Kuo, P.-L., Chiang, L.-C., & Lin, C.-C. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02177-x · Cited by 165
Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity
Soni, K. B., Lahiri, M., Chackradeo, P., Bhide, S. V., & Kuttan, R. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04710-1 · Cited by 154
Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis
Singh, P. P., & Singh, S. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt150 · Cited by 152
Self-citationWogan, G. N., Kensler, T. W., & Groopman, J. D. (2011) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2011.563370 · Cited by 146
The mTOR Pathway in Hepatic Malignancies
Bhat, M., Sonenberg, N., & Gores, G. J. (2013) · Hepatology · doi:10.1002/hep.26323 · Cited by 144
Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
Chang, C., Lin, J., Wu, L., Lai, M., & Chuang, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1162 · Cited by 133
Holloway, M. (1994) · Scientific American · doi:10.1038/scientificamerican0894-76 · Cited by 128
Statin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study
Chiu, H., Ho, S., Chen, C., & Yang, C. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.475 · Cited by 121
Wen, C.-P., Lin, J. M., Yang, Y. C., Tsai, M. K., Tsao, C. K., Etzel, C. J., Huang, M., Hsu, C. Y., Ye, Y., Mishra, L., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs372 · Cited by 120
Chou, R., Hartung, D. M., Rahman, B., Wasson, N., Cottrell, E. B., & Fu, R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-2-201301150-00576 · Cited by 113
Cancer incidence among patients treated with antidiabetic pharmacotherapy
Oliveria, S. A., Koro, C. E., Yood, M. U., & Sowell, M. O. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2007.11.002 · Cited by 89
Liver precancerous lesions and hepatocellular carcinoma: The histology report
Roncalli, M. G., Terracciano, L., Tommaso, L. D., David, E., & Colombo, M. (2011) · Digestive and Liver Disease · doi:10.1016/s1590-8658(11)60592-6 · Cited by 81
Kawaguchi, T., Taniguchi, E., Morita, Y., Shirachi, M., Tateishi, I., Nagata, E., & Sata, M. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02191.x · Cited by 78
Vitamin Intake and Liver Cancer Risk: A Report From Two Cohort Studies in China
Zhang, W., Shu, X., Li, H., Yang, G., Cai, H., Ji, B.-T., Gao, J., Gao, Y., Zheng, W., & Xiang, Y. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs277 · Cited by 78
Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs
Okumura, T. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0310-9 · Cited by 67
Falk, G. W., Buttar, N. S., Foster, N. R., Ziegler, K. L. A., DeMars, C. J., Romero, Y., Marcon, N. E., Schnell, T. G., Corley, D. A., Sharma, P., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.044 · Cited by 65
Samadder, N. J., Mukherjee, B., Huang, S., Ahn, J., Rennert, H. S., Greenson, J. K., Rennert, G., & Gruber, S. B. (2010) · Cancer · doi:10.1002/cncr.25731 · Cited by 60
Is It Time to Write a Prescription for Coffee? Coffee and Liver Disease
Torres, D. M., & Harrison, S. A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.015 · Cited by 58
The multifaceted mechanisms for coffee’s anti-tumorigenic effect on liver
Tao, K., Wang, W., Wang, L., Cao, D., Li, Y., Wu, S., & Dou, K. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.06.026 · Cited by 57
Anti-hepatoma activity of resveratrol in vitro
Zhong-jie, S. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i1.79 · Cited by 48
Rui, R., Lou, J., Zou, L., Zhong, R., Wang, J., Ding, X., Wang, Q., Li, H., Wu, J., Lu, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044522 · Cited by 47
Functional role of peroxisome‐proliferator‐activated receptor γ in hepatocellular carcinoma
Wu, C., Farrell, G. C., & Yu, J. Q. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07213.x · Cited by 46
Postoperative Use of the Chemopreventive Vitamin K2 Analog in Patients with Hepatocellular Carcinoma
Zhong, J., Mo, X.-S., Xiang, B., Yuan, W., Jiang, J., Xie, G., & Li, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058082 · Cited by 40
Coffee Drinking and Hepatocellular Carcinoma
Bravi, F., Bosetti, C., Tavani, A., et al. (2009) · Hepatology · doi:10.1002/hep.23272 · Cited by 32
Statins and Risk Reduction in Hepatocellular Carcinoma: Fact or Fiction?
Singh, P. P., & Singh, S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2179 · Cited by 12
Self-citationRe: Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
Singh, P. P., & Singh, S. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt062 · Cited by 7
Self-citation
Cited by
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Fujiwara, N., Friedman, S. L., Goossens, N., & Hoshida, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.016 · Cited by 659
DeWaal, D., Nogueira, V., Terry, A. R., Patra, K. C., Jeon, S.-M., Guzman, G., Au, J., Long, C. P., Antoniewicz, M. R., & Hay, N. (2018) · Nature Communications · doi:10.1038/s41467-017-02733-4 · Cited by 525
Yang, J., Pi, C., & Wang, G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.072 · Cited by 450
Korean Liver Cancer Association, K., & National Cancer Center, N. (2019) · Gut and Liver · doi:10.5009/gnl19024 · Cited by 391
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Hou, J., Karin, M., & Sun, B. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00459-9 · Cited by 366
Metadata
- Authors
- Singh, S., Singh, P. P., Roberts, L. R., & Sanchez, W.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2013-08-13
- Volume
- 11
- Issue
- 1
- Pages
- 45-54
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2021181675
- Cited by
- 273
- References
- 111
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.